Sibold William John's Form 4 filing
Madrigal Pharmaceuticals, Inc.MDGL · filed Jul 20, 2026
- Accession no.
- 0001628280-26-048919
- Filed
- Jul 20, 2026, 9:16 PM ET
- Trade date
- Jul 17-20, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.37M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sibold William JohnCIK 0001518611 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | –F1 | – | 211,829 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −140 | $542.75F3 | −$75,984.43 | 211,689 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −110 | $543.79F4 | −$59,817.22 | 211,579 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −545 | $544.71F5 | −$296,869.13 | 211,034 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −275 | $545.71F6 | −$150,070.03 | 210,759 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −269 | $547.08F7 | −$147,164.2 | 210,490 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −680 | $547.70F8 | −$372,434.64 | 209,810 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −47 | $548.87F9 | −$25,796.98 | 209,763 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −153 | $550.01F10 | −$84,152.11 | 209,610 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −1 | $550.72 | −$550.72 | 209,609 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −280 | $555.05F11 | −$155,414 | 209,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On July 17, 2026, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 12. Pursuant to the terms of the award, certain of these shares were sold to cover certain tax withholding obligations as described in Footnote 2 below. The Issuer is irrevocably obligated to issue the remaining shares to the Reporting Person on September 8, 2029, the sixth anniversary of the commencement of his employment with the Issuer.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.22 to $543.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.26 to $544.25, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.31 to $545.28, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.31 to $546.29, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.37 to $547.35, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.40 to $548.29, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.42 to $549.39, inclusive.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.70 to $550.24, inclusive.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.10, inclusive.
Referenced by the price of 1 transaction in Table I.